Literature DB >> 23583912

The structure of yeast glutaminyl-tRNA synthetase and modeling of its interaction with tRNA.

Thomas D Grant1, Joseph R Luft, Jennifer R Wolfley, Mary E Snell, Hiro Tsuruta, Stephanie Corretore, Erin Quartley, Eric M Phizicky, Elizabeth J Grayhack, Edward H Snell.   

Abstract

Eukaryotic glutaminyl-tRNA synthetase (GlnRS) contains an appended N-terminal domain (NTD) whose precise function is unknown. Although GlnRS structures from two prokaryotic species are known, no eukaryotic GlnRS structure has been reported. Here we present the first crystallographic structure of yeast GlnRS, finding that the structure of the C-terminal domain is highly similar to Escherichia coli GlnRS but that 214 residues, including the NTD, are crystallographically disordered. We present a model of the full-length enzyme in solution, using the structures of the C-terminal domain, and the isolated NTD, with small-angle X-ray scattering data of the full-length molecule. We proceed to model the enzyme bound to tRNA, using the crystallographic structures of GatCAB and GlnRS-tRNA complex from bacteria. We contrast the tRNA-bound model with the tRNA-free solution state and perform molecular dynamics on the full-length GlnRS-tRNA complex, which suggests that tRNA binding involves the motion of a conserved hinge in the NTD.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583912      PMCID: PMC3859906          DOI: 10.1016/j.jmb.2013.03.043

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  50 in total

1.  Functional redundancy in the nonspecific RNA binding domain of a class I tRNA synthetase.

Authors:  C C Wang; A J Morales; P Schimmel
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

Review 2.  Aminoacyl-tRNA synthesis.

Authors:  M Ibba; D Soll
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

3.  Species barrier to RNA recognition overcome with nonspecific RNA binding domains.

Authors:  C C Wang; P Schimmel
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

Review 4.  A deliberate approach to screening for initial crystallization conditions of biological macromolecules.

Authors:  Joseph R Luft; Robert J Collins; Nancy A Fehrman; Angela M Lauricella; Christina K Veatch; George T DeTitta
Journal:  J Struct Biol       Date:  2003-04       Impact factor: 2.867

5.  tRNA-dependent active site assembly in a class I aminoacyl-tRNA synthetase.

Authors:  Luke D Sherlin; John J Perona
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

6.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

7.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

8.  Evidence for auto-inhibition by the N terminus of hADAR2 and activation by dsRNA binding.

Authors:  Mark R Macbeth; Arunth T Lingam; Brenda L Bass
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  Deinococcus glutaminyl-tRNA synthetase is a chimer between proteins from an ancient and the modern pathways of aminoacyl-tRNA formation.

Authors:  Marzanna Deniziak; Claude Sauter; Hubert Dominique Becker; Caroline Alexandra Paulus; Richard Giegé; Daniel Kern
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

View more
  7 in total

1.  A new view on crystal harvesting.

Authors:  Joseph R Luft; Thomas D Grant; Jennifer R Wolfley; Edward H Snell
Journal:  J Appl Crystallogr       Date:  2014-05-29       Impact factor: 3.304

Review 2.  RNA Structural Dynamics As Captured by Molecular Simulations: A Comprehensive Overview.

Authors:  Jiří Šponer; Giovanni Bussi; Miroslav Krepl; Pavel Banáš; Sandro Bottaro; Richard A Cunha; Alejandro Gil-Ley; Giovanni Pinamonti; Simón Poblete; Petr Jurečka; Nils G Walter; Michal Otyepka
Journal:  Chem Rev       Date:  2018-01-03       Impact factor: 60.622

3.  Structure of the ArgRS-GlnRS-AIMP1 complex and its implications for mammalian translation.

Authors:  Yaoyao Fu; Youngran Kim; Kyeong Sik Jin; Hyun Sook Kim; Jong Hyun Kim; DongMing Wang; Minyoung Park; Chang Hwa Jo; Nam Hoon Kwon; Doyeun Kim; Myung Hee Kim; Young Ho Jeon; Kwang Yeon Hwang; Sunghoon Kim; Yunje Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

Review 4.  MD Simulations of tRNA and Aminoacyl-tRNA Synthetases: Dynamics, Folding, Binding, and Allostery.

Authors:  Rongzhong Li; Lindsay M Macnamara; Jessica D Leuchter; Rebecca W Alexander; Samuel S Cho
Journal:  Int J Mol Sci       Date:  2015-07-13       Impact factor: 5.923

5.  The crystal structure of human GlnRS provides basis for the development of neurological disorders.

Authors:  Jana Ognjenović; Jiang Wu; Doreen Matthies; Ulrich Baxa; Sriram Subramaniam; Jiqiang Ling; Miljan Simonović
Journal:  Nucleic Acids Res       Date:  2016-02-10       Impact factor: 16.971

6.  Leveraging machine learning essentiality predictions and chemogenomic interactions to identify antifungal targets.

Authors:  Ci Fu; Xiang Zhang; Amanda O Veri; Kali R Iyer; Emma Lash; Alice Xue; Huijuan Yan; Nicole M Revie; Cassandra Wong; Zhen-Yuan Lin; Elizabeth J Polvi; Sean D Liston; Benjamin VanderSluis; Jing Hou; Yoko Yashiroda; Anne-Claude Gingras; Charles Boone; Teresa R O'Meara; Matthew J O'Meara; Suzanne Noble; Nicole Robbins; Chad L Myers; Leah E Cowen
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 17.694

7.  Evolutionary insights about bacterial GlxRS from whole genome analyses: is GluRS2 a chimera?

Authors:  Saumya Dasgupta; Gautam Basu
Journal:  BMC Evol Biol       Date:  2014-02-12       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.